Stocks

ELI Lilly LLY

Health care sectorNYSE

Close
$1,184.76
09/29 close
Day change
−0.1%
vs previous close
Volume
65,182
−50.6% vs 30-day average
52-week range
$717.69$1,290.80
1-year return
+63.3%
vs the close a year ago
Market cap
$1.1T
941,357,065 shares · reported 08/03

Company

Exchange
NYSE
Industry
Pharmaceutical Preparations
Headquarters
Indianapolis, Indiana
Fiscal year end
12/31
Next earnings
10/29, estimated

Members of Congress reported 8 trades in ELI Lilly LLY in the past 90 days (2 purchases, 6 sales).

Korean holdings rank
Outside the top 50
Korea Securities Depository · released 09/22
Congress trades
8
Last 90 days · 2 buys · 6 sales
Insider net buying
No record
Last 90 days · 0 buys · 0 sales
Next earnings
10/29
Estimated from the last four quarters

Price

$1,184.76Day −0.1%1 year +63.3%

26-week trading

Common questions

Which members of Congress traded ELI Lilly LLY recently?
The latest reported trades: Sen. John Boozman, partial sale on 25/11/21 (reported 08/24), Rep. Michael Rulli, full sale on 07/01 (reported 08/07), Rep. Michael Rulli, purchase on 01/02 (reported 08/07), Rep. Michael Rulli, full sale on 25/12/02 (reported 08/07) and Sen. Tommy Tuberville, full sale on 25/04/15 (reported 08/05).